What to Know in Washington: Cheaper Insulin Still Out of Reach
Bloomberg Government subscribers get the stories like this first. Act now and gain unlimited access to everything you need to know. Learn more.
Senate leaders have signaled that they want to address insulin costs this year, but the path is complicated.
More than 37 million Americans have diabetes and paying for it is eating up a greater share of their household income than ever before.
For 17 years, Kristen Whitney Daniels has been a Type 1 diabetic, needing regular doses of insulin to stay healthy. She usually reaches her insurance’s annual $3,000 out-of-pocket maximum in about two months. So when drugmaker Eli Lilly cut the list price this spring of its generic insulin—Lispro—to $25 a vial, she set out to find it at area pharmacies.
One told Whitney Daniels it had no Lispro in stock. Another was selling it for $70 a vial, she said. A third refused to sell it to her without a prescription, even though she had one for Humalog, the branded and more expensive insulin from Eli Lilly. Eight other diabetics described in interviews the same experience: None was able to find Lispro at the discounted price after it went into effect in May.
These stories showcase the complex bureaucracy diabetics face to buy insulin and the market pressures that keep prices high and low-cost alternatives and generics out of reach.
Senate leaders said they hope to get to the issue when the chamber returns from its August recess. There’s broad support to extend to private insurers Medicare’s $35-per-month cap on insulin costs; the proposal was three votes shy of becoming law last year.
Some lawmakers say more needs to be done to protect the uninsured and fix long-standing flaws in the insulin market. Doing so could mean addressing the role pharmaceutical middlemen play in the price of insulin or simply demanding that drugmakers lower their prices.
President Joe Biden has repeatedly called on Congress to extend Medicare’s $35-per-month cap on insulin costs to the private sector. Republicans supporting an insulin cap say they want any new federal spending offset with cuts elsewhere. Senate Democratic leaders have signaled they may pair insulin with other drug-pricing bills to offset the cost. Supporters of the cap say they’re trying to figure out what bill or combination of bills can garner 60 votes in the Senate. Read the full story from Alex Ruoff.
BIDEN’S AGENDA
- Biden will deliver remarks in Albuquerque, New Mexico around 3 p.m. to mark the one-year anniversary of the Inflation Reduction Act and the CHIPS Act.
US Keeps Focus on China
Revenue Rule to Limit Scope of China Investment Ban
A US plan to restrict investment in China is likely to apply only to Chinese companies that get at least half of their revenue from cutting-edge sectors such as quantum computing and AI, limiting the scope of an executive order the Biden administration is expected to unveil in the coming days as part of a push to stem Chinese access to sensitive technology
- As the US aims to reduce its reliance on Asia’s semiconductor supply chains, the Commerce Department reports it has received more than 460 statements of interest for projects in 42 states seeking federal funds or financing help from the CHIPS Act, with more than a third focused on chip fabrication. Read more.
Biden Plans Vietnam Trip
Biden said he plans to travel to Vietnam soon as the US seeks to bolster its ties with Asian nations and reduce China’s influence on the region.
Politics & 2024
Abortion Ballot Fight Ramps Up After Ohio Initiative Defeated
Ohio abortion rights backers have a clearer path to victory in November now that voters refused to make it harder to amend the state constitution. Those pushing for a reproductive rights amendment will only need to convince a simple majority of the electorate rather than the 60% sought by the Republican-led legislature.
Mississippi Governor’s Race Spotlights Economy and Elvis’ Cousin
Mississippi Gov. Tate Reeves, who won the Republican primary on Tuesday against political newcomers David Hardigree and John Witcher, will be challenged in the general election by Democrat Brandon Presley, who’s running statewide after four terms as Northern District public service commissioner. Presley’s other claim to fame is a second-cousin connection to Elvis Presley.
What Else We’re Reading
Biden Hails Grand Canyon Monument as Investment in US
Biden declared a new national monument near the Grand Canyon, a designation that restricts future uranium mining in the area, touting it as part of his climate agenda.
First US City to Tame Inflation Owes Its Success to Housing Boom
In May, the Twin Cities became the first major metropolitan area to see annual inflation fall below the Federal Reserve’s target of 2%, largely due to a region-wide push to address one of the most intractable issues for both the Fed and American consumers: rising housing costs.
To contact the reporter on this story: Brandon Lee in Washington at blee@bgov.com
To contact the editor responsible for this story: Kayla Sharpe at ksharpe@bloombergindustry.com
Stay informed with more news like this – from the largest team of reporters on Capitol Hill – subscribe to Bloomberg Government today. Learn more.